Avidity Biosciences to Participate in Upcoming Investor Conferences

On August 31, 2021 Avidity Biosciences, Inc. (NASDAQ: RNA) a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), reported that the Avidity management team will be participating at the following conferences (Press release, Avidity Biosciences, AUG 31, 2021, View Source [SID1234587066]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2021 Wells Fargo Virtual Healthcare Conference
September 9th, 2021
11:20am ET – Fireside Chat

Chardan Virtual 5th Annual Genetic Medicines Conference
October 5th, 2021
12noon ET – Panel titled "RNA-based Targeted Delivery Approaches"
1:30pm ET – Fireside Chat

Live webcasts of each event, as well as an archived replay of the webcasts following each event, will be available on the "Events and Presentations" page in the "Investors" section of Avidity’s website at View Source